BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/13/2016 8:23:00 AM | Browse: 1771 | Download: 3087
Publication Name World Journal of Stem Cells
Manuscript ID 22635
Country Italy
ISSN 1948-0210 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell Biology
Manuscript Type Review
Article Title Human induced pluripotent stem cells for monogenic disease modelling and therapy
Manuscript Source Invited Manuscript
All Author List Paola Spitalieri, Valentina Rosa Talarico, Michela Murdocca, Giuseppe Novelli and Federica Sangiuolo
Funding Agency and Grant Number
Funding Agency Grant Number
Agenzia Spaziale Italiana, CoReA 2013-084-R.0
Corresponding Author Federica Sangiuolo, PhD, Department of Biomedicine and Prevention, Tor Vergata University, via Montpellier, 1, 00133 Rome, Italy. sangiuolo@med.uniroma2.it
Key Words Human induced pluripotent stem cells; Gene therapy; Monogenic diseases; Gene editing; Foetal cells; Reprogramming techniques; Differentiation
Core Tip With the development of human induced pluripotent stem cells (hiPSCs) deriving from patients, we can begin to understand the molecular mechanisms underlying monogenic diseases and consequently identify new drugs for their treatment. hiPSCs can differentiate into many disease-relevant cell types, providing in this way to innovative applications in the field of cell replacement therapy, disease modelling, drug testing and drug discovery.
Publish Date 2016-04-13 13:33
Citation Spitalieri P, Talarico VR, Murdocca M, Novelli G, Sangiuolo F. Human induced pluripotent stem cells for monogenic disease modelling and therapy. World J Stem Cells 2016; 8(4): 118-135
URL http://www.wjgnet.com/1948-0210/full/v8/i4/118.htm
DOI http://dx.doi.org/10.4252/wjsc.v8.i4.118
Full Article (PDF) WJSC-8-118.pdf
Full Article (Word) WJSC-8-118.doc